Traws Pharma's total assets for Q4 2025 were $10.62M, a decrease of -32.04% from the previous quarter. TRAW total liabilities were $11.25M for the fiscal quarter, a 52.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.